Related Experiment Video
Updated: May 2, 2026

09:29
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
1.8K
Gabapentin for Substance Use Disorders: Is it Safe and Appropriate?
Journal of Psychosocial Nursing and Mental Health Services
|February 20, 2014
Summary
Gabapentin effectively treats alcohol dependence and associated symptoms like anxiety and insomnia. It is a safe option for patients with substance use disorders, even those using opioids.
Area of Science:
- Pharmacology
- Addiction Medicine
- Public Health
Background:
- Unintentional drug overdose deaths are rising in the US, primarily due to prescription drugs like opioids.
- Gabapentin is increasingly recognized for its therapeutic potential in managing substance use disorders.
- Assessing the safety profile of gabapentin in patients with comorbid conditions is crucial.
Purpose of the Study:
- To evaluate the efficacy of gabapentin in treating alcohol dependence.
- To determine the safety and appropriateness of gabapentin for patients with various substance use disorders (SUDs).
- To compare the safety profile of gabapentin with other psychotropic medications.
Main Methods:
- Literature review and synthesis of existing clinical data on gabapentin use.
- Analysis of gabapentin's pharmacological properties and known side effects.
- Examination of case studies and clinical trials involving patients with SUDs.
Main Results:
- Gabapentin demonstrates effectiveness in treating alcohol dependence, anxiety, insomnia, headaches, and pain in patients with SUDs.
- Gabapentin exhibits a favorable safety profile, being less harmful and lethal compared to other psychotropic drugs.
- Gabapentin is considered safe for patients with all types of SUDs, including those concurrently using opioid drugs.
Conclusions:
- Gabapentin is a valuable therapeutic agent for alcohol dependence and related symptoms in patients with or at risk for SUDs.
- The drug's safety profile supports its use in complex patient populations, including those with opioid use disorder.
- Gabapentin offers a safer alternative for managing symptoms in individuals with substance use disorders.
More Related Videos
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
1.6K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.6K
CNS Depressants: Alcohol and Nicotine
1.7K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.7K
Antiepileptic Drugs: Potassium Channel Activators
1.0K
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
1.0K
Substance Use Disorders Affecting Sleep
610
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
610
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.7K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.7K
CNS Depressants: Barbiturates and Benzodiazepines
1.9K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.9K

